ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag evolution biodiversity infectious disease culture

Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
The Scientist Staff | Mar 28, 2024
Steps to End “Colonial Science” Slowly Take Shape
Ashley Yeager | Jan 1, 2021 | 10 min read
Scientists from countries with fewer resources are pushing collaborators from higher-income countries to shed biases and behaviors that perpetuate social stratification in the research community.
New Antibiotic from Soil Bacteria
Anna Azvolinsky | Jan 7, 2015 | 3 min read
Researchers have isolated a new kind of antibiotic from a previously unknown and uncultured bacterial genus.  
Lost Colonies
Anna Azvolinsky | Oct 1, 2015 | 10+ min read
Next-generation sequencing has identified scores of new microorganisms, but getting even abundant bacterial species to grow in the lab has proven challenging.
Top 10 Innovations 2014
The Scientist | Dec 1, 2014 | 10+ min read
The list of the year’s best new products contains both perennial winners and innovative newcomers.
Researchers Receiving MacArthur Fellowships Demonstrate 'Capacity To Make A Difference'
Bruce Anderson | Sep 14, 1997 | 6 min read
PRIZE WITH A PRICE: Science historian Peter Galison has taken some ribbing from his family since being named a MacArthur fellow. One could almost pity Peter Galison. A historian of science at Harvard University, Galison is one of seven members of the scientific community among the 23 recipients of this year's John D. and Catherine T. MacArthur Foundation Fellowships. The coveted five-year awards provide unrestricted support plus health insurance to talented individuals, with no reports or proj
Biotech Startups' Business And Science Missions Must Be Crystal Clear From Day One, Experts Say
Ricki Lewis | Apr 18, 1993 | 9 min read
Smarter consumership and rigid demands from investors leave little room for fuzzy thinking in entrepreneurial plans Despite recent setbacks in drug approvals, the mounting campaign for cost-cutting in the health care industry, and ongoing tribulations in the United States and global financial markets, the domestic biotechnology startup world is apparently holding its own. As the industry at large matures, analysts say, new entrants are learning from the highly publicized mistakes of their pr

Run a Search

ADVERTISEMENT